Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



FDA to crack down on potentially unsafe homeopathic treatments

The US Food and Drug Administration (FDA) has announced its intention to introduce a new “risk-based enforcement approach” to protect consumers from unproven homeopathic products that could be potentially harmful to their health.  According to the Center for Drug Evaluation and...

Read More

Two type 2 diabetes drugs from Merck and Pfizer gain FDA approval

Pharmacies in the United States will soon stock two more medications for treating type 2 diabetes after pharmaceutical giants Merck and Pfizer had a pair of products approved by the US Food and Drug Administration (FDA). Steglujan (ertugliflozin and sitagliptin) and Steglatro (ertugliflozin) were...

Read More

Aurobindo’s generic Seroquel XR receives FDA approval

Aurobindo Pharma has received US Food and Drug Administration approval for its quetiapine fumarate extended-release tablets (50mg, 150mg, 200mg, 300mg, and 400mg). The medication is a bioequivalent of the AstraZeneca drug Seroquel XR and is therapeutically equivalent to this...

Read More

FDA approves first nebulized LAMA treatment for COPD

The US Food and Drug Administration (FDA) has approved Sunovion’s Lonhala Magnair (glycopyrrolate), making it the first nebulized long-acting muscarinic antagonist (LAMA) treatment in the United States for patients with chronic obstructive pulmonary disease (COPD). It is expected to appear in...

Read More

Fiasp: New Rapid-Acting Mealtime Insulin Approved by FDA

Adults with type 1 or type 2 diabetes have a new treatment option available to them following the US Food and Drug Administration’s (FDA) decision to approve Novo Nordisk's rapid-acting mealtime insulin Fiasp (insulin aspart).  The drug is indicated to improve glycemic control in adults...

Read More

Juluca: New two drug HIV treatment approved by FDA

The US Food and Drug Administration (FDA) has approved the first once-daily, two-drug single pill treatment for certain patients with human immunodeficiency virus type 1 (HIV-1). Approval for Juluca (dolutegravir and rilpivirine) was granted to ViiV Healthcare, a global specialist in HIV owned by...

Read More

Tobacco products ‘still used by 20% of American adults’

Around 49 million American adults were still using tobacco products in 2015, according to new data published by the Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration’s (FDA) Center for Tobacco Products.  The Morbidity and Mortality Weekly Report...

Read More

Trelegy Ellipta: Triple therapy inhaler for COPD approved by FDA

The US Food and Drug Administration (FDA) has approved a new once-daily single inhaler triple therapy for treatment of certain adults with chronic obstructive pulmonary disease (COPD).  Trelegy Ellipta (furoate, umeclidinium, vilanterol) is indicated for patients on a fixed-dose combination...

Read More

First ever Erdheim-Chester Disease treatment approved by FDA

Zelboraf (vemurafenib) has been approved for treatment of adult patients with a rare cancer of the blood. It is the first medication approved by the US Food and Drug Administration (FDA) for treatment of Erdheim-Chester Disease (ECD).  ECD is a rare blood cancer originating in the bone...

Read More